ALEMG Statistics

Total Valuation

Laboratoires Euromedis Société anonyme has a market cap or net worth of EUR 13.19 million. The enterprise value is 3.56 million.

Market Cap	13.19M
Enterprise Value	3.56M

Important Dates

The next estimated earnings date is Tuesday, December 24, 2024.

Earnings Date	Dec 24, 2024
Ex-Dividend Date	n/a

Share Statistics

Laboratoires Euromedis Société anonyme has 2.85 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	2.85M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	2.99%
Float	999,718

Valuation Ratios

PE Ratio	n/a
Forward PE	11.38
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.20
EV / Sales	0.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.41.

Current Ratio	2.79
Quick Ratio	2.04
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.84

Financial Efficiency

Return on equity (ROE) is 70.96% and return on invested capital (ROIC) is -1.65%.

Return on Equity (ROE)	70.96%
Return on Assets (ROA)	-1.18%
Return on Capital (ROIC)	-1.65%
Revenue Per Employee	163,193
Profits Per Employee	95,507
Employee Count	190
Asset Turnover	0.62
Inventory Turnover	2.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.13% in the last 52 weeks. The beta is -0.44, so Laboratoires Euromedis Société anonyme's price volatility has been lower than the market average.

Beta (5Y)	-0.44
52-Week Price Change	-2.13%
50-Day Moving Average	5.11
200-Day Moving Average	4.75
Relative Strength Index (RSI)	26.23
Average Volume (20 Days)	3,813

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Laboratoires Euromedis Société anonyme had revenue of EUR 31.01 million and earned 18.15 million in profits.

Revenue	31.01M
Gross Profit	2.85M
Operating Income	-948,189
Pretax Income	18.40M
Net Income	18.15M
EBITDA	-385,189
EBIT	-948,189
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 18.66 million in cash and 9.04 million in debt, giving a net cash position of 9.63 million or 3.38 per share.

Cash & Cash Equivalents	18.66M
Total Debt	9.04M
Net Cash	9.63M
Net Cash Per Share	3.38
Equity (Book Value)	22.06M
Book Value Per Share	n/a
Working Capital	24.79M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 9.20%, with operating and profit margins of -3.06% and 58.52%.

Gross Margin	9.20%
Operating Margin	-3.06%
Pretax Margin	59.35%
Profit Margin	58.52%
EBITDA Margin	-1.24%
EBIT Margin	-3.06%
FCF Margin	n/a

Dividends & Yields

Laboratoires Euromedis Société anonyme does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Laboratoires Euromedis Société anonyme has an Altman Z-Score of 1.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.75
Piotroski F-Score	n/a